The WACC of Dicerna Pharmaceuticals Inc (DRNA) is 6.6%.
| Range | Selected | |
| Cost of equity | 7.70% - 11.40% | 9.55% |
| Tax rate | 27.00% - 27.00% | 27.00% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.7% - 7.5% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 4.2% | 5.2% |
| Adjusted beta | 1.08 | 1.38 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.70% | 11.40% |
| Tax rate | 27.00% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.7% | 7.5% |
| Selected WACC | 6.6% | |